PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $352,022 | +8.1% | 11,474 | +36.1% | 0.00% | -20.0% |
| Q4 2022 | $325,598 | +48.5% | 8,433 | +2.4% | 0.01% | +150.0% |
| Q3 2022 | $219,219 | -94.2% | 8,236 | -83.3% | 0.00% | -95.6% |
| Q1 2022 | $3,762,000 | +93.4% | 49,287 | +52.4% | 0.04% | +221.4% |
| Q4 2021 | $1,945,000 | +533.6% | 32,333 | +379.5% | 0.01% | -51.7% |
| Q1 2017 | $307,000 | – | 6,743 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |